Australia - English - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - magnesium amino acid chelate,magnesium aspartate tetrahydrate,magnesium citrate,magnesium glycinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - magnesium amino acid chelate,magnesium aspartate tetrahydrate,magnesium citrate,magnesium glycinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - magnesium amino acid chelate, quantity: 300 mg (equivalent: magnesium, qty 60 mg); magnesium aspartate tetrahydrate, quantity: 150 mg (equivalent: magnesium, qty 10 mg); magnesium glycinate, quantity: 491.28 mg (equivalent: magnesium, qty 70 mg); magnesium citrate, quantity: 389 mg (equivalent: magnesium, qty 60 mg) - tablet, film coated - excipient ingredients: macrogol 400; colloidal anhydrous silica; magnesium stearate; hypromellose; microcrystalline cellulose; titanium dioxide; croscarmellose sodium; carnauba wax; citric acid - maintain/support physical endurance/capacity/stamina ; maintain/support heat/energy production/thermogenesis ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; maintain/support bone health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; decrease/reduce/relieve muscle cramps ; helps reduce occurrence of muscle cramp ; helps decrease/reduce/relieve mild muscle spasms/twitches ; maintain/support healthy muscle contraction function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support muscle relaxation ; maintain/support muscle strength ; decrease/reduce/relieve muscle tiredness ; maintain/support muscle performance/endurance/stamina ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; decrease/reduce/relieve restlessness/excess nervous energy ; maintain/support nerve conduction ; maintain/support neuromuscular function ; decrease/reduce/relieve sleeplessness ; maintain/support healthy sleeping patterns ; decrease/reduce feelings of aggression/irritability associated with premenstrual tension ; decrease/reduce/relieve mood changes/mood swings associated with premenstrual tension ; decrease/reduce/relieve breast pain/tenderness associated with premenstrual tension ; decrease/reduce/relieve symptoms of premenstrual tension

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - magnesium aspartate tetrahydrate, quantity: 153.85 mg (equivalent: magnesium, qty 10 mg); magnesium glycinate, quantity: 496.45 mg (equivalent: magnesium, qty 70 mg); magnesium citrate, quantity: 388.35 mg (equivalent: magnesium, qty 60 mg); magnesium amino acid chelate, quantity: 300 mg (equivalent: magnesium, qty 60 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; hypromellose; citric acid; colloidal anhydrous silica; isomalt; rice starch; medium chain triglycerides - maintain/support physical endurance/capacity/stamina ; maintain/support heat/energy production/thermogenesis ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; maintain/support bone health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; decrease/reduce/relieve muscle cramps ; helps reduce occurrence of muscle cramp ; helps decrease/reduce/relieve mild muscle spasms/twitches ; maintain/support healthy muscle contraction function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support muscle relaxation ; maintain/support muscle strength ; decrease/reduce/relieve muscle tiredness ; maintain/support muscle performance/endurance/stamina ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; decrease/reduce/relieve restlessness/excess nervous energy ; maintain/support nerve conduction ; maintain/support neuromuscular function ; decrease/reduce/relieve sleeplessness ; maintain/support healthy sleeping patterns ; decrease/reduce feelings of aggression/irritability associated with premenstrual tension ; decrease/reduce/relieve mood changes/mood swings associated with premenstrual tension ; decrease/reduce/relieve breast pain/tenderness associated with premenstrual tension ; decrease/reduce/relieve symptoms of premenstrual tension

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - magnesium aspartate tetrahydrate, quantity: 153.85 mg (equivalent: magnesium, qty 10 mg); magnesium glycinate, quantity: 496.45 mg (equivalent: magnesium, qty 70 mg); magnesium citrate, quantity: 388.35 mg (equivalent: magnesium, qty 60 mg); magnesium amino acid chelate, quantity: 300 mg (equivalent: magnesium, qty 60 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; hypromellose; citric acid; colloidal anhydrous silica; isomalt; rice starch; medium chain triglycerides - maintain/support physical endurance/capacity/stamina ; maintain/support heat/energy production/thermogenesis ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; maintain/support bone health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; decrease/reduce/relieve muscle cramps ; helps reduce occurrence of muscle cramp ; helps decrease/reduce/relieve mild muscle spasms/twitches ; maintain/support healthy muscle contraction function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support muscle relaxation ; maintain/support muscle strength ; decrease/reduce/relieve muscle tiredness ; maintain/support muscle performance/endurance/stamina ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; decrease/reduce/relieve restlessness/excess nervous energy ; maintain/support nerve conduction ; maintain/support neuromuscular function ; decrease/reduce/relieve sleeplessness ; maintain/support healthy sleeping patterns ; decrease/reduce feelings of aggression/irritability associated with premenstrual tension ; decrease/reduce/relieve mood changes/mood swings associated with premenstrual tension ; decrease/reduce/relieve breast pain/tenderness associated with premenstrual tension ; decrease/reduce/relieve symptoms of premenstrual tension

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - magnesium glycinate, quantity: 491.28 mg (equivalent: magnesium, qty 70 mg); magnesium citrate, quantity: 389 mg (equivalent: magnesium, qty 60 mg); magnesium aspartate tetrahydrate, quantity: 150 mg (equivalent: magnesium, qty 10 mg); magnesium amino acid chelate, quantity: 300 mg (equivalent: magnesium, qty 60 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; titanium dioxide; carnauba wax; croscarmellose sodium; citric acid; magnesium stearate; colloidal anhydrous silica; macrogol 400 - maintain/support physical endurance/capacity/stamina ; maintain/support heat/energy production/thermogenesis ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; maintain/support bone health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; decrease/reduce/relieve muscle cramps ; helps reduce occurrence of muscle cramp ; helps decrease/reduce/relieve mild muscle spasms/twitches ; maintain/support healthy muscle contraction function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support muscle relaxation ; maintain/support muscle strength ; decrease/reduce/relieve muscle tiredness ; maintain/support muscle performance/endurance/stamina ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; decrease/reduce/relieve restlessness/excess nervous energy ; maintain/support nerve conduction ; maintain/support neuromuscular function ; decrease/reduce/relieve sleeplessness ; maintain/support healthy sleeping patterns ; decrease/reduce feelings of aggression/irritability associated with premenstrual tension ; decrease/reduce/relieve mood changes/mood swings associated with premenstrual tension ; decrease/reduce/relieve breast pain/tenderness associated with premenstrual tension ; decrease/reduce/relieve symptoms of premenstrual tension

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [see warnings]

United States - English - NLM (National Library of Medicine)

contract pharmacy services-pa - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [

United States - English - NLM (National Library of Medicine)

proficient rx lp - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] acetaminophen and codeine phosphate tablets are contraindicated in patients with: controlled substance acetaminophen and codeine phosphate tablet contains acetaminophen and codeine phosphate, a schedule cii controlled substance. abuse acetaminophen and codeine phosphate tablet contains  codeine, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydrormorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol. acetaminophen and codeine phosphate tablets can be abused and is subject to

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [see warnings]